4-butyrolactone has been researched along with Carcinogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, X; Chen, B; Chen, S; Li, C; Lu, H; Qi, X; Wen, P; Wu, L; Xu, A; Zhao, G | 1 |
Goswami, S; Sharma-Walia, N | 1 |
2 other study(ies) available for 4-butyrolactone and Carcinogenesis
Article | Year |
---|---|
N-(3-oxo-acyl) homoserine lactone induced germ cell apoptosis and suppressed the over-activated RAS/MAPK tumorigenesis via mitochondrial-dependent ROS in C. elegans.
Topics: 4-Butyrolactone; Animals; Apoptosis; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carcinogenesis; DNA Damage; Female; Germ Cells; MAP Kinase Signaling System; Mitochondria; Mutation; Oxidative Stress; ras Proteins; Reactive Oxygen Species; RNA Interference | 2018 |
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
Topics: 4-Butyrolactone; Breast Neoplasms; Carcinogenesis; Caspase 9; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Fatty Acid Synthases; Female; Humans; Lipid Droplets; Lipid Metabolism; Molecular Targeted Therapy; Osteoprotegerin; Protein Binding; Receptor Cross-Talk; Signal Transduction; Tumor Microenvironment | 2016 |